Minerva Total Liab from 2010 to 2024
| NERV Stock | USD 3.31 0.02 0.60% |
Total Liabilities | First Reported 2012-12-31 | Previous Quarter 85.4 B | Current Value 87.1 M | Quarterly Volatility 13 B |
Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva Neurosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.5 K, Interest Expense of 8.7 M or Selling General Administrative of 10.9 B, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.
Minerva | Total Liab |
Latest Minerva Neurosciences' Total Liab Growth Pattern
Below is the plot of the Total Liab of Minerva Neurosciences over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Minerva Neurosciences' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Minerva Neurosciences' overall financial position and show how it may be relating to other accounts over time.
| Total Liab | 10 Years Trend |
|
Total Liab |
| Timeline |
Minerva Total Liab Regression Statistics
| Arithmetic Mean | 33,912,507 | |
| Geometric Mean | 11,592,837 | |
| Coefficient Of Variation | 85.31 | |
| Mean Deviation | 24,746,925 | |
| Median | 27,256,834 | |
| Standard Deviation | 28,930,410 | |
| Sample Variance | 837T | |
| Range | 85.2M | |
| R-Value | 0.80 | |
| Mean Square Error | 320.1T | |
| R-Squared | 0.64 | |
| Significance | 0.0003 | |
| Slope | 5,194,764 | |
| Total Sum of Squares | 11717.6T |
Minerva Total Liab History
About Minerva Neurosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Minerva Neurosciences income statement, its balance sheet, and the statement of cash flows. Minerva Neurosciences investors use historical funamental indicators, such as Minerva Neurosciences's Total Liab, to determine how well the company is positioned to perform in the future. Although Minerva Neurosciences investors may use each financial statement separately, they are all related. The changes in Minerva Neurosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Minerva Neurosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Minerva Neurosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Liabilities | 85.4 M | 42.7 M |
Pair Trading with Minerva Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Minerva Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Minerva Stock
| 0.66 | ELUT | Elutia Inc Symbol Change | PairCorr |
Moving against Minerva Stock
The ability to find closely correlated positions to Minerva Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Minerva Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Minerva Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Minerva Neurosciences to buy it.
The correlation of Minerva Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Minerva Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Minerva Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Minerva Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.